This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
In a landmark move for the pharmaceutical industry, Novo Nordisk has announced a strategic partnership with OpenAI. The collaboration aims to integrate advanced artificial intelligence across the company
